PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-205 Cr | ₹-235 Cr | ₹-346 Cr | ₹-181 Cr | ₹-1,571 Cr |
What is the latest Cash Flow from Financing Activities ratio of PFIZER ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-205 Cr |
| Mar2024 | ₹-235 Cr |
| Mar2023 | ₹-346 Cr |
| Mar2022 | ₹-181 Cr |
| Mar2021 | ₹-1,571 Cr |
How is Cash Flow from Financing Activities of PFIZER Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-205 Cr | Negative | |
| Mar2024 | ₹-235 Cr | Negative | |
| Mar2023 | ₹-346 Cr | Negative | |
| Mar2022 | ₹-181 Cr | Negative | |
| Mar2021 | ₹-1,571 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹22,023.5 Cr | 0.3% | -3.9% | -7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 0.3% |
-3.9% |
-7.6% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses